Larvol Delta - A-MultiCenter-Randomized-Double-Masked-Placebo-Controlled-Clinical-Study-to-Assess-the-Safety-and-Efficacy-of-BRM421-for-Dry-Eye-Syndrome

BRM421 - BRIM Biotechnology

http://clinicaltrials.gov/ct2/show/NCT04343287

Apr 13, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev